High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMA

scientific article published on 01 January 1989

High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMA is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-0609.1989.TB00242.X
P698PubMed publication ID2644129

P2093author name stringA Neri
F Mandelli
G Avvisati
G Leone
M C Petti
V Liso
P Leoni
S Amadori
A De Laurenzi
A Covelli
P433issue1
P304page(s)24-31
P577publication date1989-01-01
P1433published inEuropean Journal of HaematologyQ15765799
P1476titleHigh-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMA
P478volume42

Reverse relations

cites work (P2860)
Q60171409Acute megakaryoblastic leukemia: experience of GIMEMA trials
Q40485001Acute myeloid leukaemia in the elderly: biology and treatment
Q33684133Acute myeloid leukemia in the elderly: 'per aspera ad astra'?
Q37424101Acute myeloid leukemia in the elderly: biological features and search for adequate treatment
Q73127004Adult acute leukemia
Q37732543Chemotherapy of acute myelogenous leukaemia
Q64897905Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.
Q40485380The Approach to the Elderly Patient with Acute Myeloid Leukemia
Q37904928The toxicity of cytarabine

Search more.